Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 1
2009 3
2010 1
2011 4
2012 4
2013 3
2014 6
2015 4
2016 4
2017 3
2018 4
2019 1
2020 4
2021 5
2022 6
2023 7
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Mohsenian S, Palla R, Menegatti M, Cairo A, Lecchi A, Casini A, Neerman-Arbez M, Asselta R, Scardo S, Siboni SM, Blatny J, Zapletal O, Schved JF, Giansily-Blaizot M, Halimeh S, Daoud MA, Platokouki H, Pergantou H, Schutgens REG, Van Haaften-Spoor M, Brons P, Laros-van Gorkom B, Van Pinxten E, Borhany M, Fatima N, Mikovic D, Saracevic M, Özdemir GN, Ay Y, Makris M, Lockley C, Mumford A, Harvey A, Austin S, Shapiro A, Williamson A, McGuinn C, Goldberg I, De Moerloose P, Peyvandi F. Mohsenian S, et al. Among authors: siboni sm. Blood Adv. 2024 Mar 26;8(6):1392-1404. doi: 10.1182/bloodadvances.2023012186. Blood Adv. 2024. PMID: 38286442 Free PMC article.
Updates on Novel Non-Replacement Drugs for Hemophilia.
Gualtierotti R, Pasca S, Ciavarella A, Arcudi S, Giachi A, Garagiola I, Suffritti C, Siboni SM, Peyvandi F. Gualtierotti R, et al. Among authors: siboni sm. Pharmaceuticals (Basel). 2022 Sep 23;15(10):1183. doi: 10.3390/ph15101183. Pharmaceuticals (Basel). 2022. PMID: 36297295 Free PMC article. Review.
Anti-emicizumab antibodies do not cross-react with mim8 in vitro.
Valsecchi C, Gualtierotti R, Arcudi S, Ciavarella A, Siboni SM, Schiavone L, Beeg M, Gobbi M, Peyvandi F. Valsecchi C, et al. Among authors: siboni sm. Res Pract Thromb Haemost. 2023 Aug 8;7(6):102161. doi: 10.1016/j.rpth.2023.102161. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694267 Free PMC article. No abstract available.
Genetic determinants of enhanced von Willebrand factor clearance from plasma.
Seidizadeh O, Baronciani L, Pagliari MT, Cozzi G, Colpani P, Cairo A, Siboni SM, Biguzzi E, Peyvandi F. Seidizadeh O, et al. Among authors: siboni sm. J Thromb Haemost. 2023 May;21(5):1112-1122. doi: 10.1016/j.jtha.2023.01.012. Epub 2023 Jan 20. J Thromb Haemost. 2023. PMID: 36754679 Free article.
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.
Seidizadeh O, Mollica L, Zambarbieri S, Baronciani L, Cairo A, Colpani P, Cozzi G, Pagliari MT, Ciavarella A, Siboni SM, Peyvandi F. Seidizadeh O, et al. Among authors: siboni sm. Blood Adv. 2024 Apr 9;8(7):1725-1736. doi: 10.1182/bloodadvances.2024012626. Blood Adv. 2024. PMID: 38315875 Free PMC article.
58 results